GMO Equity Dislocation Fund, L.P. is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed May 28, 2026, the fund has sold $2,711,885,753 of interests to 172 investors since its first sale in Nov 2020. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Douglas Keith; Tara Pari; David Bohan.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $2,711,885,753Cumulative sales reported on Form D
- Investors
- 172
- First sale
- Nov 30, 2020
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Douglas Keith; Tara Pari; David Bohan
- Latest Form D
- May 28, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about GMO Equity Dislocation Fund, L.P.
What is the minimum investment for GMO Equity Dislocation Fund, L.P.?
GMO Equity Dislocation Fund, L.P.'s latest Form D, filed May 28, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in GMO Equity Dislocation Fund, L.P.?
GMO Equity Dislocation Fund, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has GMO Equity Dislocation Fund, L.P. raised?
GMO Equity Dislocation Fund, L.P. reports $2,711,885,753 sold from 172 investors on its Form D filed May 28, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is GMO Equity Dislocation Fund, L.P. based?
GMO Equity Dislocation Fund, L.P. is based in Boston, Massachusetts.
When did GMO Equity Dislocation Fund, L.P. launch?
GMO Equity Dislocation Fund, L.P. reports its first sale in Nov 2020.
Size compared with every hedge fund
Raised more than 93% of the 474 hedge funds based in Massachusetts, and more than 97% of all 10,308 that report sales.
Other funds with the same team
- GMO Equity Dislocation Fund (Offshore), L.P.$1.1B
- GMO Amplified Equity Dislocation Solution Fund, L.P.$1.0B
- FICG-GM-I Fund, L.P.$787M
- Manatee Cove Partners EMD Fund, L.P.$500M
- GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV$180M
- GMO Emerging Country Debt UCITS Fund, a sub-fund of GMO Investments ICAV$87.5M
- GMO World Market Neutral Fund, L.P.$85.0M
More hedge funds in Boston
Similar-size hedge funds in Massachusetts
- PanAgora Risk Parity Multi Asset (12V), LLC$2.7B
- Risk Parity Multi-Asset Fund, a series of The PanAgora Group Trust$2.7B
- Independent Return, LLC$2.6B
- Arrowstreet ACWI Alpha Extension Fund V (Cayman) Ltd$2.8B
- Arrowstreet Emerging Market Alpha Extension Trust Fund, a sub-fund of the Arrowstreet Investment Trust$2.5B
- Arrowstreet ACWI ex US Alpha Extension Trust Fund U, a sub-fund of the Arrowstreet Investment Trust$2.9B